Insider · CIK 0001189543

PAPPAS ARTHUR M

Reports to the SEC for 6 companies · DURHAM, NC

sec.gov

Transactions

Companies

Filings

CIK

0001189543

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2018-07-30	Liquidia Technologies IncC Conversion	10% Owner	CConversion	+192K sh	—	—	191,788
2018-07-30	Liquidia Technologies IncC Conversion	10% Owner	CConversion	+97.3K sh	—	—	289,075
2018-07-30	Liquidia Technologies IncSeries C Preferred Stock, par value $0.001 per shareC Conversion	10% Owner	CConversion	−1.48M sh	—	—	0
2018-07-30	Liquidia Technologies IncSeries D Preferred Stock, par value $0.001 per shareC Conversion	10% Owner	CConversion	−1.64M sh	—	—	0
2018-06-25	KZRKezar Life Sciences, Inc.C Conversion	10% Owner	CConversion	+291K sh	—	—	290,924
2018-06-25	KZRKezar Life Sciences, Inc.C Conversion	10% Owner	CConversion	+23.9K sh	—	—	23,894
2018-06-25	KZRKezar Life Sciences, Inc. · Series B Preferred Stock, par value $0.001 per shareC Conversion	10% Owner	CConversion	+291K sh	—	—	0
2018-06-25	KZRKezar Life Sciences, Inc. · Series B Preferred Stock, par value $0.001 per shareC Conversion	10% Owner	CConversion	+23.9K sh	—	—	0
2017-03-01	CoLucid Pharmaceuticals, Inc.U Disposition from Tender	Director, 10% Owner	UDisposition from Tender	−1.87M sh	$46.50	−$87M	0
2017-03-01	CoLucid Pharmaceuticals, Inc.U Disposition from Tender	Director, 10% Owner	UDisposition from Tender	−116K sh	$46.50	−$5.41M	0
2017-03-01	CoLucid Pharmaceuticals, Inc.U Disposition from Tender	Director, 10% Owner	UDisposition from Tender	−5,528 sh	$46.50	−$257K	0
2017-03-01	CoLucid Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−5,954 sh	$36.50	−$217K	0
2017-03-01	CoLucid Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−8,897 sh	$40.26	−$358K	0
2016-05-10	CoLucid Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director, 10% Owner	AAward	+8,897 sh	—	—	8,897
2015-05-11	CoLucid Pharmaceuticals, Inc.C Conversion	Director, 10% Owner	CConversion	+1.59M sh	—	—	1,588,609
2015-05-11	CoLucid Pharmaceuticals, Inc.C Conversion	Director, 10% Owner	CConversion	+98.8K sh	—	—	98,757
2015-05-11	CoLucid Pharmaceuticals, Inc.P Purchase	Director, 10% Owner	PPurchase	+282K sh	$10.00	+$2.82M	1,871,049
2015-05-11	CoLucid Pharmaceuticals, Inc.P Purchase	Director, 10% Owner	PPurchase	+17.6K sh	$10.00	+$176K	116,317
2015-05-11	CoLucid Pharmaceuticals, Inc.Series A Convertible Preferred StockC Conversion	Director, 10% Owner	CConversion	−578K sh	—	—	0
2015-05-11	CoLucid Pharmaceuticals, Inc.Series A Convertible Preferred StockC Conversion	Director, 10% Owner	CConversion	−36K sh	—	—	0
2015-05-11	CoLucid Pharmaceuticals, Inc.Series B Convertible Preferred StockC Conversion	Director, 10% Owner	CConversion	−676K sh	—	—	0
2015-05-11	CoLucid Pharmaceuticals, Inc.Series B Convertible Preferred StockC Conversion	Director, 10% Owner	CConversion	−42K sh	—	—	0
2015-05-11	CoLucid Pharmaceuticals, Inc.Series C Convertible Preferred StockC Conversion	Director, 10% Owner	CConversion	−335K sh	—	—	0
2015-05-11	CoLucid Pharmaceuticals, Inc.Series C Convertible Preferred StockC Conversion	Director, 10% Owner	CConversion	−20.8K sh	—	—	0
2015-05-05	CoLucid Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director, 10% Owner	AAward	+5,954 sh	—	—	5,954
2015-03-23	CoLucid Pharmaceuticals, Inc.M Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	+5,528 sh	$4.07	+$22.5K	5,528
2015-03-23	CoLucid Pharmaceuticals, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	−5,528 sh	—	—	0
2015-01-12	CoLucid Pharmaceuticals, Inc.Series A Convertible Preferred StockP Purchase	Director, 10% Owner	PPurchase	+463K sh	—	—	462,637
2015-01-12	CoLucid Pharmaceuticals, Inc.Series A Convertible Preferred StockP Purchase	Director, 10% Owner	PPurchase	+28.8K sh	—	—	28,763
2015-01-12	CoLucid Pharmaceuticals, Inc.Series B Convertible Preferred StockP Purchase	Director, 10% Owner	PPurchase	+540K sh	—	—	540,470
2015-01-12	CoLucid Pharmaceuticals, Inc.Series B Convertible Preferred StockP Purchase	Director, 10% Owner	PPurchase	+33.6K sh	—	—	33,597
2015-01-12	CoLucid Pharmaceuticals, Inc.Series C Convertible Preferred StockP Purchase	Director, 10% Owner	PPurchase	+335K sh	—	—	334,722
2015-01-12	CoLucid Pharmaceuticals, Inc.Series C Convertible Preferred StockP Purchase	Director, 10% Owner	PPurchase	+20.8K sh	—	—	20,808
2013-10-23	CHIMERIX INCS Sale	Director	SSale	−217K sh	$15.51	−$3.36M	830,695
2013-04-16	CHIMERIX INCC Conversion	Director	CConversion	+893K sh	—	—	1,047,535
2012-04-16	CHIMERIX INCSeries F Preferred StockC Conversion	Director	CConversion	−3.17M sh	—	—	0
2007-06-29	ATHEROGENICS INCNon-qualified stock option (right to buy)A Award	Director	AAward	+6,000 sh	—	—	6,000
2006-04-27	ATHEROGENICS INCP Purchase	Director	PPurchase	+3,000 sh	$14.03	+$42.1K	11,000
2003-09-25	QUINTILES TRANSNATIONAL CORPD Disposition to Issuer	Director	DDisposition to Issuer	−3,600 sh	$14.50	−$52.2K	0
2003-09-25	QUINTILES TRANSNATIONAL CORPStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−9,250 sh	—	—	0
2003-09-25	QUINTILES TRANSNATIONAL CORPStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−6,000 sh	—	—	0
2003-09-25	QUINTILES TRANSNATIONAL CORPStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,000 sh	—	—	0
2003-09-25	QUINTILES TRANSNATIONAL CORPStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−4,242 sh	—	—	0
2003-09-25	QUINTILES TRANSNATIONAL CORPStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−4,242 sh	—	—	0
2003-09-25	QUINTILES TRANSNATIONAL CORPStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−3,001 sh	—	—	0
2003-09-25	QUINTILES TRANSNATIONAL CORPStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−8,432 sh	—	—	0
2003-09-25	QUINTILES TRANSNATIONAL CORPStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12K sh	—	—	0
2003-09-25	QUINTILES TRANSNATIONAL CORPStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−7,926 sh	—	—	0
2003-09-25	QUINTILES TRANSNATIONAL CORPStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−2,352 sh	—	—	0
2003-09-25	QUINTILES TRANSNATIONAL CORPStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−3,208 sh	—	—	0

Recent filings

Accepted (ET)
Aug 14
PAPPAS CAPITAL, LLC0001144204-18-041397
SEC(opens sec.gov)
Jun 264
PAPPAS ARTHUR M0001144204-18-035850
SEC(opens sec.gov)
Mar 14
CoLucid Pharmaceuticals, Inc.0000911916-17-000086
SEC(opens sec.gov)
May 124
CoLucid Pharmaceuticals, Inc.0000911916-16-000558
SEC(opens sec.gov)
May 124
CoLucid Pharmaceuticals, Inc.0000911916-15-000189
SEC(opens sec.gov)

Companies

Address

C/O CHIMERIX, INC. 2505 MERIDIAN PARKWAY, SUITE 340

DURHAM, NC, 27713